AlphAIAlphAI — Financial news for AI agents
investing.comNOV 32 min read$HSIC

Henry Schein earnings beat by $0.20, revenue fell short of estimates

Henry Schein (HSIC) reported Q3 EPS of $1.56, beating estimates by $0.20, but revenue of $3.47B missed expectations. The company guided FY 2026 EPS to $5.50-$5.56, above consensus. Stock is down 1.82% over 3 months but up 20.96% year-over-year. InvestingPro rates its financial health as 'good performance'.

Original reporting
investing.com
Published Nov 3, 2026, 11:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$HSIC
Bullish
high confidence
Mentioned
$HSIC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HSICBullishHigh
01

Why it matters

The earnings beat and raised guidance may trigger buying interest, but the slight revenue miss could temper enthusiasm.

02

Market read

HSIC's earnings surprise provides a fresh catalyst for the stock and its sector.

03

What to watch

Potential cost pressures or competitive pricing could temper upside despite the EPS beat.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Henry Schein is a leading distributor of health care products and services; its earnings are closely watched by sector investors.

Company-level read

Ticker impact

$HSICBullishHigh confidence
Context

HSIC reported Q3 EPS of $1.56 beating estimates by $0.20 and raised FY2026 guidance to $5.50-$5.56.

Expected impact

likely modest upside as market prices in the earnings beat and raised outlook

Evidence & confidence

The beat and guidance lift expectations; investors typically bid the stock higher on such news.

Market effects

Sector

Positive for dental and medical supply distributors as HSIC signals demand strength.

Regional

U.S. healthcare distribution sector may see modest rally.

Global

Limited to U.S. markets; no direct global effect.

Counterpoint

What could challenge this read

If the revenue miss signals underlying demand weakness, the stock could face short‑term pressure.

Key entities

  • company
    Henry Schein

    U.S. health‑care distribution firm (NASDAQ: HSIC).

Read at source← All news

StoryHenry Schein beats Q3 profit estimates and raises FY2026 guidance

Also covered by

5 outlets

Related articles

NOV 3
$HSICMedAI 8/10

What Henry Schein (HSIC) Said on Its Q3 Earnings Call

Henry Schein (HSIC) reported Q3 earnings, noting pressure in discretionary procedures but strong growth in global dental and specialty products. U.S. dental equipment sales rose 1.6%, while global distribution and value-added services increased 3.7%. The company raised its non-GAAP EPS outlook to $5.50-$5.56. Management expects 2026 sales growth of 4.5%-5.5% and high-single-digit adjusted EBITDA growth.

finance.yahoo.com6 min
NOV 3
$HSICMedAI 8/10

Henry Schein, Inc. Q3 2026 Earnings Call Summary

Henry Schein reported Q3 2026 US dental merchandise growth of 8.6%, driven by volume. The company targets $200M in operating income improvements by 2026, with $125M expected by year-end. Non-GAAP EPS guidance raised to $5.50–$5.56. Management expects double-digit EPS growth in 2027, supported by value creation initiatives and portfolio shifts. Q3 included a $0.19 per share tariff refund benefit and $22M in restructuring expenses. Emmanuel Capre will succeed Ronald South as CFO in November 2026.

finance.yahoo.com6 min
NOV 3
$HSICHighAI 8/10

HENRY SCHEIN REPORTS STRONG 2026 THIRD QUARTER AND RAISES FY2026 GUIDANCE

HENRY SCHEIN INC (HSIC) filed an SEC Form 8-K — Results of Operations and Financial Condition. -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS STRONG 2026 THIRD QUARTER AND RAISES FY2026 GUIDANCE ● Q3 2026 GAAP diluted EPS of $1.06, up 26.2% versus prior year; Q3 2026 non-GAAP diluted EPS of $1.56, up 13.0% versus prior year ● 4.0% total sales growth, driven by 8.6% U.

SEC EDGAR 8-K2 min
NOV 3
$HSICHighAI 8/10

Henry Schein Q3 Earnings, Sales Climb; Lifts 2026 Adj. Income Outlook

Henry Schein (HSIC) reported Q3 fiscal 2026 earnings of $1.06 per share, up from $0.84 a year ago, with adjusted profit at $1.37 per share. Revenue rose to $3.471 billion. The company raised its 2026 adjusted earnings outlook to $5.50-$5.56 per share, citing tariff refunds and improved performance. HSIC shares were down 0.14% pre-market.

rttnews.com1 min